<DOC>
	<DOCNO>NCT01820481</DOCNO>
	<brief_summary>This clinical trial design evaluate efficacy , dose-response safety WIN-901X Asthma patient .</brief_summary>
	<brief_title>Safety Efficacy WIN-901X Asthma</brief_title>
	<detailed_description>Double blind , Randomized , Placebo Controlled , Multi-center , Phase 2 : Exploratory Clinical Study Evaluate Efficacy , Dose-response Safety WIN-901X Asthma Patients</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Greater equal 20 less 80 year age Have physician diagnose asthma irreversible airway obstruction least 6 month prior screen FEV1 60 % 85 % inhale fastacting bronchodilator screen No history smoke least one year prior screen Having voluntarily sign inform consent Have visit emergency room due worsen asthma symptom , within 4 week screen Have hospitalize due acute worsen asthma within 3 month screen Have history laryngitis , pyrexia , sinusitis , otitis medium , respiratory tract infection , infectious rhinitis within 4 week prior screen Have malignant tumor</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Bronchial Diseases</keyword>
	<keyword>Respiratory Tract Diseases</keyword>
	<keyword>Lung Diseases , Obstructive</keyword>
	<keyword>Lung Diseases</keyword>
</DOC>